Neil Blumenthal reports multiple 10b5-1 sales

Neil Blumenthal reported 10b5-1 sales of Common Stock executed through Morgan Stanley Smith Barney LLC on multiple dates in 2026.

Rhea-AI Filing Summary

Neil Blumenthal reported 10b5-1 sales of Common Stock executed through Morgan Stanley Smith Barney LLC on multiple dates in 2026. The filing lists sales of 63,040, 22,442, 75,213, and 2,345 shares with the corresponding gross proceeds shown for each trade.

Insights

Equity Capital Markets Specialist

Transactions are routine, scheduled dispositions under 10b5-1 plans.

These entries list executed 10b5-1 sales of Common Stock through Morgan Stanley Smith Barney LLC with specific share counts and gross proceeds for each date. The pattern and explicit "10b5-1 Sales" label indicate pre-arranged plan executions rather than discretionary open-market timing.

Cash‑flow treatment shows gross proceeds per trade; the filing does not state net proceeds to the seller or how proceeds are used. Subsequent filings may disclose additional sales or withholding details.

Securities Compliance Analyst

Form 144 records resale transactions and broker facilitation, not an offering by the issuer.

The filing identifies Morgan Stanley Smith Barney LLC as the broker and lists ‘‘Previously Exercised Options and Restricted Stock Units’’ as the source for 36,300 shares noted elsewhere. Form 144s document intended resale by affiliates or insiders and broker execution details.

Monitor public filings for any Form 4 or 144 amendments if additional detail on beneficial ownership or post‑sale holdings is required.

Key Figures

Sale on 05/19/2026: 63,040 shares Sale on 04/20/2026: 22,442 shares Sale on 04/17/2026: 75,213 shares +2 more

5 metrics

Sale on 05/19/2026 63,040 shares 10b5-1 sale, gross proceeds $1,893,236.19

Sale on 04/20/2026 22,442 shares 10b5-1 sale, gross proceeds $562,957.57

Sale on 04/17/2026 75,213 shares 10b5-1 sale, gross proceeds $1,847,748.44

Sale on 04/16/2026 2,345 shares 10b5-1 sale, gross proceeds $56,466.66

Previously sourced shares 36,300 shares Listed as "Previously Exercised Options and Restricted Stock Units" dated 06/28/2017

Key Terms

10b5-1, Form 144, Restricted Stock Units

3 terms

10b5-1 regulatory

"10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street,"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Previously Exercised Options and Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

What did Neil Blumenthal report for WRBY in this Form 144?

He reported multiple 10b5-1 sales of Common Stock executed through Morgan Stanley Smith Barney LLC. The filing lists specific trades on 04/16/2026, 04/17/2026, 04/20/2026, and 05/19/2026, with share counts and gross proceeds.

How many shares were sold under the 10b5-1 entries in this excerpt?

The listed trades show 63,040, 22,442, 75,213, and 2,345 shares sold on the dated transactions. Each row pairs the share count with gross proceeds in dollars.

Who executed the trades and what broker is named in the filing?

Trades were executed through Morgan Stanley Smith Barney LLC, named as the broker in the Form 144 excerpt. The filing attributes the listed 10b5-1 sales to Neil Blumenthal and provides broker contact details.

Does the filing state the source of the shares sold?

Yes; the excerpt includes a line noting "Previously Exercised Options and Restricted Stock Units" as the source tied to a 36,300 share entry dated 06/28/2017. Other sold shares are identified as 10b5-1 sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883345
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Warby Parker Inc.
SEC File Number	001-40825
Address of Issuer	233 Spring Street, 6th Floor East New York NEW YORK 10013
Phone	6468477215
Name of Person for Whose Account the Securities are To Be Sold	NEIL BLUMENTHAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	36300	1061412.00	107094174	06/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/28/2017	Previously Exercised Options and Restricted Stock Units	Issuer			36300	06/28/2017	Cash and N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	05/19/2026	63040	1893236.19
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/20/2026	22442	562957.57
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/17/2026	75213	1847748.44
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/16/2026	2345	56466.66

144: Remarks and Signature

Remarks	The securities to be sold were or will be acquired upon the vesting of restricted stock units and previously exercised options during the period of 06/28/2017 through 12/31/2023.
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil Blumenthal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)